Hearing results following intratympanic gentamicin perfusion for Ménière’s disease
Conclusion: Intratympanic gentamicin perfusion provides effective control of vertigo in patients with Ménière’s disease. However, significant hearing loss may occur immediately after perfusion; therefore, this treatment should be considered only for patients whose hearing has already been affected by the disease.
from the Journal of Laryngology and Otology
Posted on March 31, 2009, in Research and tagged gentamicin, Meniere's disease, middle ear, sensorineural deafness. Bookmark the permalink. Leave a Comment.

Leave a Comment
Comments (0)